Pages that link to "Q71852099"
Jump to navigation
Jump to search
The following pages link to Intrathecal morphine in mice: a new technique (Q71852099):
Displaying 50 items.
- Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception. (Q24534017) (← links)
- Spinal cord mechanisms mediating behavioral hyperalgesia induced by neurokinin-1 tachykinin receptor activation in the rostral ventromedial medulla (Q24624781) (← links)
- Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions (Q24626122) (← links)
- The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptors (Q24630886) (← links)
- Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids (Q24634901) (← links)
- Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia (Q24648394) (← links)
- Antagonists of the kappa-opioid receptor enhance allodynia in rats and mice after sciatic nerve ligation (Q24672417) (← links)
- Pharmacological profiles of a novel opioid receptor-like1 (ORL(1)) receptor antagonist, JTC-801 (Q24673352) (← links)
- Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase (Q24683304) (← links)
- Pre-injury administration of morphine prevents development of neuropathic hyperalgesia through activation of descending monoaminergic mechanisms in the spinal cord in mice (Q24811385) (← links)
- Genetic reduction of chronic muscle pain in mice lacking calcium/calmodulin-stimulated adenylyl cyclases (Q25257407) (← links)
- Intrathecal bone marrow stromal cells inhibit neuropathic pain via TGF-β secretion (Q27332195) (← links)
- Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models (Q28191762) (← links)
- DREAM is a critical transcriptional repressor for pain modulation (Q28215587) (← links)
- A monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch relief (Q28240662) (← links)
- Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception (Q28240697) (← links)
- Spinal mitogen-activated protein kinase phosphatase-3 (MKP-3) is necessary for the normal resolution of mechanical allodynia in a mouse model of acute postoperative pain (Q28300818) (← links)
- Evidence for the involvement of spinal endogenous ATP and P2X receptors in nociceptive responses caused by formalin and capsaicin in mice (Q28343805) (← links)
- Contribution of alpha(2) receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidine (Q28363081) (← links)
- Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice (Q28363126) (← links)
- Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice (Q28365869) (← links)
- Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors (Q28378301) (← links)
- Absence of prostaglandin E2-induced hyperalgesia in NMDA receptor epsilon subunit knockout mice (Q28379551) (← links)
- Discovery of prostamide F2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability (Q28480988) (← links)
- Enhanced nociception by exogenous and endogenous substance P given into the spinal cord in mice lacking NR(2)A/epsilon(1), an NMDA receptor subunit (Q28505549) (← links)
- Characterization of nociceptin/orphanin FQ-induced pain responses in conscious mice: neonatal capsaicin treatment and N-methyl-D-aspartate receptor GluRepsilon subunit knockout mice (Q28509205) (← links)
- Morphine and clonidine combination therapy improves therapeutic window in mice: synergy in antinociceptive but not in sedative or cardiovascular effects (Q28543670) (← links)
- Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice (Q28571306) (← links)
- Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene (Q28590329) (← links)
- Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system (Q28591665) (← links)
- Lack of the nociceptin receptor does not affect acute or chronic nociception in mice (Q28591699) (← links)
- A Wnt5a signaling pathway in the pathogenesis of HIV-1 gp120-induced pain (Q28604010) (← links)
- Spinal Botulinum Neurotoxin B: Effects on Afferent Transmitter Release and Nociceptive Processing (Q28740599) (← links)
- Mouse current vocalization threshold measured with a neurospecific nociception assay: the effect of sex, morphine, and isoflurane (Q30462485) (← links)
- A Peripheral Adrenoceptor-mediated Sympathetic Mechanism Can Transform Stress-induced Analgesia into Hyperalgesia (Q30466917) (← links)
- Antinociceptive effect of cyclic phosphatidic acid and its derivative on animal models of acute and chronic pain (Q30501034) (← links)
- Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist (Q30541205) (← links)
- Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects (Q30631622) (← links)
- Toll-like receptor 4 contributes to chronic itch, alloknesis, and spinal astrocyte activation in male mice (Q30785636) (← links)
- 1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain. (Q31170459) (← links)
- The role of nitric oxide and prostaglandin E2 on the hyperalgesia induced by excitatory amino acids in rats (Q31374928) (← links)
- Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice. (Q31432554) (← links)
- Antinociceptive effects after intrathecal administration of phosphodiester-, 2'-O-allyl-, and C-5-propyne-modified antisense oligodeoxynucleotides targeting the NMDAR1 subunit in mouse (Q31878282) (← links)
- The role of spinal cholecystokinin B receptors in thermal allodynia and hyperalgesia in diabetic mice (Q31924146) (← links)
- Alleviation of behavioral hypersensitivity in mouse models of inflammatory pain with two structurally different casein kinase 1 (CK1) inhibitors (Q33559650) (← links)
- Upregulation of casein kinase 1epsilon in dorsal root ganglia and spinal cord after mouse spinal nerve injury contributes to neuropathic pain (Q33583147) (← links)
- Protein kinase C mediates the synergistic interaction between agonists acting at alpha2-adrenergic and delta-opioid receptors in spinal cord (Q33643934) (← links)
- The role of kinin B1 and B2 receptors in the scratching behaviour induced by proteinase-activated receptor-2 agonists in mice (Q33690760) (← links)
- N-Methyl-D-aspartate receptor (NMDAR) independent maintenance of inflammatory pain. (Q33701859) (← links)
- β-arrestin-2 regulates NMDA receptor function in spinal lamina II neurons and duration of persistent pain (Q33814944) (← links)